GABAA-receptor activation in the subthalamic nucleus compensates behavioral asymmetries in the hemiparkinsonian rat

Behavioural Brain Research

Volumn 252, Issue , 2013, Pages 58-67

  Petri, David ^a   Pum, Martin ^a   Vesper, Jan ^a   Huston, Joseph P ^a   Schnitzler, Alfons ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

6 OHDA; MK 801; Muscimol; Parkinson's disease; STN; Turning behavior

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DIZOCILPINE; DOPAMINE; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXIDOPAMINE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; DIAGNOSTIC AGENT; DIZOCILPINE MALEATE; HOMOVANILLIC ACID; N METHYL DEXTRO ASPARTIC ACID; NEUROPROTECTIVE AGENT; PALLADIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; DRUG MECHANISM; ELECTROSTIMULATION; LOCOMOTION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS; Γ-AMINOBUTYRIC ACID; 6-HYDROXYDOPAMINE; 6-OHDA; ANIMAL; BRAIN DEPTH STIMULATION; DA; DBS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; GLOBUS PALLIDUS EXTERNA; GLOBUS PALLIDUS INTERNA; GPE; GPI; HEMISPHERIC DOMINANCE; HIGH PERFORMANCE LIQIUID CHROMATOGRAPHY WITH COUPLED ELECTROCHEMICAL DETECTION; HPLC-EC; I.P.; INTRAPERITONEAL DRUG ADMINISTRATION; L-3,4-DIHYDROXYPHENYLALANINE; L-DOPA; MEDIAL FOREBRAIN BUNDLE; MENTAL DISEASE; METABOLISM; MFB; MK-801; MOVEMENT RELATED BETA DESYNCHRONISATION; MRBD; N-METHYL-D-ASPARTATE; NONPARAMETRIC TEST; PARKINSON DISEASE; PHYSIOLOGY; PRIMARY MOTOR CORTEX; SNR; STN; SUBSTANTIA NIGRA PARS RETICULATA; TIME; TURNING SYNDROME; WISTAR RAT;

Γ-AMINOBUTYRIC ACID; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; 6-HYDROXYDOPAMINE; 6-OHDA; DA; DBS; DEEP BRAIN STIMULATION; DOPAC; DOPAMINE; GABA; GLOBUS PALLIDUS EXTERNA; GLOBUS PALLIDUS INTERNA; GPE; GPI; HIGH PERFORMANCE LIQIUID CHROMATOGRAPHY WITH COUPLED ELECTROCHEMICAL DETECTION; HOMOVANILLIC ACID; HPLC-EC; HVA; I.P.; INTRAPERITONEAL; L-3,4-DIHYDROXYPHENYLALANINE; L-DOPA; M1; MEDIAL FOREBRAIN BUNDLE; MFB; MK-801; MOVEMENT RELATED BETA DESYNCHRONISATION; MPTP; MRBD; MUSCIMOL; N-METHYL-D-ASPARTATE; NMDA; PARKINSON'S DISEASE; PD; PRIMARY MOTOR AREA; SNR; STN; SUBSTANTIA NIGRA PARS RETICULATA; SUBTHALAMIC NUCLEUS; TURNING BEHAVIOR;

3,4-DIHYDROXYPHENYLACETIC ACID; ADRENERGIC AGENTS; AMPHETAMINE; ANIMALS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNCTIONAL LATERALITY; GABA-A RECEPTOR AGONISTS; HOMOVANILLIC ACID; MALE; MEDIAL FOREBRAIN BUNDLE; MENTAL DISORDERS; MUSCIMOL; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, WISTAR; RECEPTORS, GABA-A; STATISTICS, NONPARAMETRIC; SUBTHALAMIC NUCLEUS; TIME FACTORS;

EID: 84879353378     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.05.044     Document Type: Article

References (76)

1. Galeffi F., Bianchi L., Bolam J.P., Della C.L. The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis. European Journal of Neuroscience 2003, 18:856-868.
2. Pan H.S., Penney J.B., Young A.B. Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. Journal of Neurochemistry 1985, 45:1396-1404.
3. Darvesh A.S., Carroll R.T., Geldenhuys W.J., Gudelsky G.A., Klein J., Meshul C.K., et al. In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. Expert Opinion on Drug Discovery 2011, 6:109-127.
4. Deniau J.M., Degos B., Bosch C., Maurice N. Deep brain stimulation mechanisms: beyond the concept of local functional inhibition. European Journal of Neuroscience 2010, 32:1080-1091.
5. Sharott A., Magill P.J., Harnack D., Kupsch A., Meissner W., Brown P. Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat. European Journal of Neuroscience 2005, 21:1413-1422.
6. Degos B., Deniau J.M., Chavez M., Maurice N. Chronic but not acute dopaminergic transmission interruption promotes a progressive increase in cortical beta frequency synchronization: relationships to vigilance state and akinesia. Cerebral Cortex 2009, 19:1616-1630.
7. Magill P.J., Sharott A., Harnack D., Kupsch A., Meissner W., Brown P. Coherent spike-wave oscillations in the cortex and subthalamic nucleus of the freely moving rat. Neuroscience 2005, 132:659-664.
8. Brown P., Mazzone P., Oliviero A., Altibrandi M.G., Pilato F., Tonali P.A., et al. Effects of stimulation of the subthalamic area on oscillatory pallidal activity in Parkinson's disease. Experimental Neurology 2004, 188:480-490.
9. Kuhn A.A., Williams D., Kupsch A., Limousin P., Hariz M., Schneider G.H., et al. Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance. Brain 2004, 127:735-746.
10. Weinberger M., Mahant N., Hutchison W.D., Lozano A.M., Moro E., Hodaie M., et al. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. Journal of Neurophysiology 2006, 96:3248-3256.
11. Tai C.H., Boraud T., Bezard E., Bioulac B., Gross C., Benazzouz A. Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB Journal 2003, 17:1820-1830.
12. Schnitzler A., Gross J. Normal and pathological oscillatory communication in the brain. Nature Reviews Neuroscience 2005, 6:285-296.
13. Kafetzopoulos E., Papadopoulos G. Turning behavior after unilateral lesion of the subthalamic nucleus in the rat. Behavioural Brain Research 1983, 8:217-223.
14. Burbaud P., Gross C., Benazzouz A., Coussemacq M., Bioulac B. Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons. Experimental Brain Research 1995, 105:48-58.
15. Piallat B., Benazzouz A., Benabid A.L. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. European Journal of Neuroscience 1996, 8:1408-1414.
16. Meissner W., Harnack D., Paul G., Reum T., Sohr R., Morgenstern R., et al. Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats. Neuroscience Letters 2002, 328:105-108.
17. Scheel-Kruger J., Magelund G. GABA in the entopeduncular nucleus and the subthalamic nucleus participates in mediating dopaminergic striatal output functions. Life Sciences 1981, 29:1555-1562.
18. Levy R., Lang A.E., Dostrovsky J.O., Pahapill P., Romas J., Saint-Cyr J., et al. Lidocaine and muscimol microinjections in subthalamic nucleus reverse Parkinsonian symptoms. Brain 2001, 124:2105-2118.
19. Gradinaru V., Mogri M., Thompson K.R., Henderson J.M., Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009, 324:354-359.
20. Aziz T.Z., Peggs D., Agarwal E., Sambrook M.A., Crossman A.R. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate. British Journal of Neurosurgery 1992, 6:575-582.
21. Fang X., Sugiyama K., Akamine S., Sun W., Namba H. The different performance among motor tasks during the increasing current intensity of deep brain stimulation of the subthalamic nucleus in rats with different degrees of the unilateral striatal lesion. Neuroscience Letters 2010, 480:64-68.
22. Shi L.H., Woodward D.J., Luo F., Anstrom K., Schallert T., Chang J.Y. High-frequency stimulation of the subthalamic nucleus reverses limb-use asymmetry in rats with unilateral 6-hydroxydopamine lesions. Brain Research 2004, 1013:98-106.
23. Spieles-Engemann A.L., Behbehani M.M., Collier T.J., Wohlgenant S.L., Steece-Collier K., Paumier K., et al. Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss. Neurobiology of Disease 2010, 39:105-115.
24. Vlamings R., Visser-Vandewalle V., Koopmans G., Joosten E.A., Kozan R., Kaplan S., et al. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats. Neuroscience 2007, 148:815-823.
25. Wichmann T., Bergman H., DeLong M.R. The primate subthalamic nucleus III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. Journal of Neurophysiology 1994, 72:521-530.
26. Baron M.S., Wichmann T., Ma D., DeLong M.R. Effects of transient focal inactivation of the basal ganglia in parkinsonian primates. Journal of Neuroscience 2002, 22:592-599.
27. Tachibana Y., Iwamuro H., Kita H., Takada M., Nambu A. Subthalamo-pallidal interactions underlying parkinsonian neuronal oscillations in the primate basal ganglia. European Journal of Neuroscience 2011, 34:1470-1484.
28. Windels F., Carcenac C., Poupard A., Savasta M. Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus. Journal of Neuroscience 2005, 25:5079-5086.
29. Ampe B., Massie A., D'Haens J., Ebinger G., Michotte Y., Sarre S. NMDA-mediated release of glutamate and GABA in the subthalamic nucleus is mediated by dopamine: an in vivo microdialysis study in rats. Journal of Neurochemistry 2007, 103:1063-1074.
30. Hatzipetros T., Yamamoto B.K. Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra. Brain Research 2006, 1076:60-67.
31. Bruet N., Windels F., Bertrand A., Feuerstein C., Poupard A., Savasta M. High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats. Journal of Neuropathology and Experimental Neurology 2001, 60:15-24.
32. Pazo J.H., Hocht C., Barcelo A.C., Fillipini B., Lomastro M.J. Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine. Synapse 2010, 64:905-915.
33. Murer M.G., Pazo J.H. Circling behaviour induced by activation of GABAA receptors in the subthalamic nucleus. Neuroreport 1993, 4:1219-1222.
34. Mehta A., Menalled L., Chesselet M.F. Behavioral responses to injections of muscimol into the subthalamic nucleus: temporal changes after nigrostriatal lesions. Neuroscience 2005, 131:769-778.
35. Blandini F., Greenamyre J.T., Fancellu R., Nappi G. Blockade of subthalamic glutamatergic activity corrects changes in neuronal metabolism and motor behavior in rats with nigrostriatal lesions. Neurological Sciences 2001, 22:49-50.
36. Miwa H., Nishi K., Fuwa T., Mizuno Y. Postural effects of unilateral blockade of glutamatergic neurotransmission in the subthalamic nucleus on haloperidol-induced akinesia in rats. Neuroscience Letters 1998, 252:167-170.
37. Murer G., Tseng K., Sinay V., Penalva R., Armando I., Pazo J.H. Turning behavior induced by injections of glutamate receptor antagonists into the substantia nigra of the rat. Synapse 1996, 24:147-155.
38. St-Pierre J.A., Bedard P.J. Intranigral but not intrastriatal microinjection of the NMDA antagonist MK-801 induces contralateral circling in the 6-OHDA rat model. Brain Research 1994, 660:255-260.
39. Morelli M., Di C.G. MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease. European Journal of Pharmacology 1990, 182:611-612.
40. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiologica Scandinavica. Supplementum 1971, 367:49-68.
41. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1996, Academic Press, New York. 6th ed.
42. Francardo V., Recchia A., Popovic N., Andersson D., Nissbrandt H., Cenci M.A. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to l-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Neurobiology of Disease 2011, 42:327-340.
43. Martin J.H., Ghez C. Pharmacological inactivation in the analysis of the central control of movement. Journal of Neuroscience Methods 1999, 86:145-159.
44. Dupre K.B., Eskow K.L., Negron G., Bishop C. The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat. Brain Research 2007, 1158:135-143.
45. Pum M.E., Schable S., Harooni H.E., Topic B., De Souza Silva M.A., Li J.S., et al. Effects of intranasally applied dopamine on behavioral asymmetries in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal tract. Neuroscience 2009, 162:174-183.
46. Chao O.Y., Mattern C., Silva A.M., Wessler J., Ruocco L.A., Nikolaus S., et al. Intranasally applied l-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions. Brain Research Bulletin 2012, 87:340-345.
47. Chao O.Y., Huston J.P., von B.A., Pum M.E. Chronic progesterone treatment of male rats with unilateral 6-hydroxydopamine lesion of the dorsal striatum exasperates parkinsonian symptoms. Neuroscience 2011, 196:228-236.
48. Bergman H., Wichmann T., DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990, 249:1436-1438.
49. Salin P., Manrique C., Forni C., Kerkerian-Le G.L. High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. Journal of Neuroscience 2002, 22:5137-5148.
50. Pritzel M., Huston J.P., Sarter M. Behavioral and neuronal reorganization after unilateral substantia nigra lesions: evidence for increased interhemispheric nigrostriatal projections. Neuroscience 1983, 9:879-888.
51. Lieu C.A., Subramanian T. The interhemispheric connections of the striatum: implications for Parkinson's disease and drug-induced dyskinesias. Brain Research Bulletin 2012, 87:1-9.
52. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends in Neurosciences 1989, 12:366-375.
53. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends in Neurosciences 1990, 13:281-285.
54. Fan K.Y., Baufreton J., Surmeier D.J., Chan C.S., Bevan M.D. Proliferation of external globus pallidus-subthalamic nucleus synapses following degeneration of midbrain dopamine neurons. Journal of Neuroscience 2012, 32:13718-13728.
55. Hall S.D., Stanford I.M., Yamawaki N., McAllister C.J., Ronnqvist K.C., Woodhall G.L., et al. The role of GABAergic modulation in motor function related neuronal network activity. Neuroimage 2011, 56:1506-1510.
56. Gaetz W., Edgar J.C., Wang D.J., Roberts T.P., Relating MEG measured motor cortical oscillations to resting gamma-aminobutyric acid (GABA) concentration. Neuroimage 2011, 55:616-621.
57. Dostrovsky J.O., Levy R., Wu J.P., Hutchison W.D., Tasker R.R., Lozano A.M. Microstimulation-induced inhibition of neuronal firing in human globus pallidus. Journal of Neurophysiology 2000, 84:570-574.
58. Feuerstein T.J., Kammerer M., Lucking C.H., Moser A., Selective GABA release as a mechanistic basis of high-frequency stimulation used for the treatment of neuropsychiatric diseases. Naunyn-Schmiedebergs Archives of Pharmacology 2011, 384:1-20.
59. Robledo P., Feger J. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Research 1990, 518:47-54.
60. Ammari R., Bioulac B., Garcia L., Hammond C. The subthalamic nucleus becomes a generator of bursts in the dopamine-depleted state, its high frequency stimulation dramatically weakens transmission to the globus pallidus. Frontiers in Systems Neuroscience 2011, 5:43.
61. Montgomery E.B., Gale J.T. Mechanisms of action of deep brain stimulation (DBS). Neuroscience and Biobehavioral Reviews 2008, 32:388-407.
62. McIntyre C.C., Hahn P.J. Network perspectives on the mechanisms of deep brain stimulation. Neurobiology of Disease 2010, 38:329-337.
63. Hallworth N.E., Bevan M.D. Globus pallidus neurons dynamically regulate the activity pattern of subthalamic nucleus neurons through the frequency-dependent activation of postsynaptic GABAA and GABAB receptors. Journal of Neuroscience 2005, 25:6304-6315.
64. Williams S.F., Herberg L.J. Motivational vs. motor effects of striatal and pallidal gabergic projections to subthalamic and entopeduncular nuclei, ventromedial thalamus, and ventral globus pallidus. Pharmacology Biochemistry and Behavior 1987, 26:49-55.
65. Baufreton J., Atherton J.F., Surmeier D.J., Bevan M.D. Enhancement of excitatory synaptic integration by GABAergic inhibition in the subthalamic nucleus. Journal of Neuroscience 2005, 25:8505-8517.
66. Baufreton J., Kirkham E., Atherton J.F., Menard A., Magill P.J., Bolam J.P., et al. Sparse but selective and potent synaptic transmission from the globus pallidus to the subthalamic nucleus. Journal of Neurophysiology 2009, 102:532-545.
67. Wichmann T., DeLong M.R., Guridi J., Obeso J.A. Milestones in research on the pathophysiology of Parkinson's disease. Movement Disorders 2011, 26:1032-1041.
68. Kozlowski M.R., Marshall J.F. Rotation induced by intranigral injections of GABA agonists and antagonists: zone-specific effects. Pharmacology Biochemistry and Behavior 1980, 13:561-567.
69. Kilpatrick I.C., Starr M.S. Involvement of dopamine in circling responses to muscimol depends on intranigral site of injection. European Journal of Pharmacology 1981, 69:407-419.
70. Tapia R., Flores-Hernandez J. Circling behavior induced by intranigral administration of ruthenium red and 4-aminopyridine in the rat. Neuroscience 1990, 39:657-663.
71. Grace A.A., Bunney B.S. Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. European Journal of Pharmacology 1979, 59:211-218.
72. Maurice N., Thierry A.M., Glowinski J., Deniau J.M. Spontaneous and evoked activity of substantia nigra pars reticulata neurons during high-frequency stimulation of the subthalamic nucleus. Journal of Neuroscience 2003, 23:9929-9936.
73. Bergmann O., Winter C., Meissner W., Harnack D., Kupsch A., Morgenstern R., et al. Subthalamic high frequency stimulation induced rotations are differentially mediated by D1 and D2 receptors. Neuropharmacology 2004, 46:974-983.
74. Allers K.A., Bergstrom D.A., Ghazi L.J., Kreiss D.S., Walters J.R. MK801 and amantadine exert different effects on subthalamic neuronal activity in a rodent model of Parkinson's disease. Experimental Neurology 2005, 191:104-118.
75. Schwarting R.K., Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Progress in Neurobiology 1996, 50:275-331.
76. Miller R., Beninger R.J. On the interpretation of asymmetries of posture and locomotion produced with dopamine agonists in animals with unilateral depletion of striatal dopamine. Progress in Neurobiology 1991, 36:229-256.